Keywords
антипсихотиклар
дофамин рецепторлари,
шизофрения,
фармакотерапия,
How to Cite
Abstract
Ушбу мақолада нейролептик препаратларнинг фармакологик хусусиятлари, таснифи, таъсир механизмлари ва клиник қўлланилишига оид замонавий маълумотлар тизимли равишда баён этилган. Биринчи, иккинчи ва учинчи авлод нейролептиклари қиёсий таҳлил қилиниб, уларнинг клиник афзалликлари ва ножўя таъсирлари кўриб чиқилган. Мақола психиатрия амалиётида рационал фармакотерапияни танлашга ёрдам беради.
References
1. Stahl S.M. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press, 2021. — 608 b.
2. Sadock B.J., Sadock V.A., Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry. 11th ed. Wolters Kluwer, 2019. — 1472 b.
3. Correll C.U., Schooler N.R. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatric Disease and Treatment, 2020;16:519–534.
4. Leucht S. et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet, 2013;382(9896):951–962.
5. Kane J.M., Correll C.U. Pharmacologic Treatment of Schizophrenia. Dialogues in Clinical Neuroscience, 2010;12(3):345–357.
This work is licensed under a Creative Commons Attribution 4.0 International License.
